289 related articles for article (PubMed ID: 29879194)
1. Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the "rubber effect".
Ziakas PD; Kourbeti IS; Poulou LS; Vlachogeorgos GS; Mylonakis E
PLoS One; 2018; 13(6):e0198674. PubMed ID: 29879194
[TBL] [Abstract][Full Text] [Related]
2. Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries.
Wheelock KM; Ross JS; Murugiah K; Lin Z; Krumholz HM; Khera R
JAMA Netw Open; 2021 Dec; 4(12):e2137288. PubMed ID: 34870678
[TBL] [Abstract][Full Text] [Related]
3. Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study.
Fleischman W; Agrawal S; King M; Venkatesh AK; Krumholz HM; McKee D; Brown D; Ross JS
BMJ; 2016 Aug; 354():i4189. PubMed ID: 27540015
[TBL] [Abstract][Full Text] [Related]
4. Direct oral anticoagulant prescription trends, switching patterns, and adherence in Texas Medicaid.
Wong SL; Marshall LZ; Lawson KA
Am J Manag Care; 2018 Jul; 24(8 Spec No.):SP309-SP314. PubMed ID: 30020743
[TBL] [Abstract][Full Text] [Related]
5. Medicare Part D payments for neurologist-prescribed drugs.
De Lott LB; Burke JF; Kerber KA; Skolarus LE; Callaghan BC
Neurology; 2016 Apr; 86(16):1491-8. PubMed ID: 27009256
[TBL] [Abstract][Full Text] [Related]
6. Prescribing Patterns and Costs Associated with Postoperative Eye Drop Use in Medicare Beneficiaries Undergoing Cataract Surgery.
Zafar S; Wang P; Schein OD; Srikumaran D; Makary M; Woreta FA
Ophthalmology; 2020 May; 127(5):573-581. PubMed ID: 31952884
[TBL] [Abstract][Full Text] [Related]
7. National Trends in Ambulatory Oral Anticoagulant Use.
Barnes GD; Lucas E; Alexander GC; Goldberger ZD
Am J Med; 2015 Dec; 128(12):1300-5.e2. PubMed ID: 26144101
[TBL] [Abstract][Full Text] [Related]
8. National trends in oral anticoagulant use in the United States, 2007 to 2011.
Kirley K; Qato DM; Kornfield R; Stafford RS; Alexander GC
Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):615-21. PubMed ID: 22949490
[TBL] [Abstract][Full Text] [Related]
9. Direct oral anticoagulants in real clinical practice: analysis of patient characteristics and prescribing patterns in a large teaching hospital.
Kováčová B; Červeňová J
Pharmazie; 2017 Sep; 72(9):555-560. PubMed ID: 29441984
[TBL] [Abstract][Full Text] [Related]
10. Adoption of direct oral anticoagulants for stroke prevention in atrial fibrillation.
Baker D; Wilsmore B; Narasimhan S
Intern Med J; 2016 Jul; 46(7):792-7. PubMed ID: 27040617
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Direct Oral Anticoagulants Utilization for Thromboembolism Prevention in Atrial Fibrillation.
Brais C; Larochelle J; Turgeon MH; Blais L; Farand P; Perreault S; Letemplier G; Beauchesne MF
J Pharm Pharm Sci; 2017; 20():8-14. PubMed ID: 28459661
[TBL] [Abstract][Full Text] [Related]
12. Visualizing nationwide variation in medicare Part D prescribing patterns.
Rosenberg A; Fucile C; White RJ; Trayhan M; Farooq S; Quill CM; Nelson LA; Weisenthal SJ; Bush K; Zand MS
BMC Med Inform Decis Mak; 2018 Nov; 18(1):103. PubMed ID: 30454029
[TBL] [Abstract][Full Text] [Related]
13. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
[TBL] [Abstract][Full Text] [Related]
14. Patterns in anticoagulant utilization in the Czech Republic during 2007-2017.
Maly J; Dvorackova S; Zimcikova E; Kubena AA; Kolar J; Vlcek J; Penka M; Mala-Ladova K
J Thromb Thrombolysis; 2019 Feb; 47(2):305-311. PubMed ID: 30659407
[TBL] [Abstract][Full Text] [Related]
15. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
16. Incidence of Direct Oral Anticoagulant Prescriptions in Kidney Transplant Recipients in Ontario, Canada.
Somaili M; Jeyakumar N; McArthur E; Ribic C; Sood MM; Harel Z; Molnar AO
Transplant Proc; 2020 Dec; 52(10):3144-3152. PubMed ID: 32402459
[TBL] [Abstract][Full Text] [Related]
17. Changes in Oral Anticoagulant Treatment Rates in Atrial Fibrillation before and after the Introduction of Direct Oral Anticoagulants.
Shah RU; Rupp AB; Mowery D; Zhang M; Stoddard G; Deshmukh V; Bray BE; Hess R; Rondina MT
Neuroepidemiology; 2016; 47(3-4):201-209. PubMed ID: 28135707
[TBL] [Abstract][Full Text] [Related]
18. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
Alamneh EA; Chalmers L; Bereznicki LR
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
[TBL] [Abstract][Full Text] [Related]
19. Analysis of psychiatrists' prescription of opioid, benzodiazepine, and buprenorphine in Medicare Part D in the United States.
Pan K; Silver S; Davis C
Trends Psychiatry Psychother; 2020; 42(1):48-54. PubMed ID: 32321084
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Prescribing Practices with Direct Acting Oral Anticoagulant Protocols.
Draper E; Parkhurst B; Carley B; Krueger K; Larson T; Griesbach S
Am J Cardiovasc Drugs; 2017 Dec; 17(6):475-479. PubMed ID: 28887621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
